{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:36:48Z","timestamp":1743273408647},"reference-count":37,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":1802,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Objective:<\/jats:bold> To determine the adequacy of pharmacotherapy received by patients with newly-diagnosed obsessive-compulsive disorder (OCD), based on current practice guidelines.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A 9 year (1997\u20132006) retrospective claims analysis of adults enrolled in Florida Medicaid for at least 3 continuous years was conducted to determine the percentage who received both a minimally effective duration (\u2265 8 continuous weeks) and dose of first-line OCD pharmacotherapy during the year following their first (\u201cindex\u201d) OCD diagnosis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among 2,960,421 adult (\u2265 18 years of age) enrollees, 2,921 (0.1%) were diagnosed with OCD. Among the 2,825 OCD patients without comorbid Asperger syndrome or autism, 843 had newly-diagnosed OCD and at least 12 months of follow-up data after their index diagnosis. Among these 843 patients, 588 (69.7%) received first-line OCD pharmacotherapy but only 323 (38.3%) received a minimally effective pharmacotherapy trial in the year following their index diagnosis.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Among clinically-diagnosed persons with OCD (&lt;10% of those with the disorder), a minority of newly-diagnosed patients receive a minimally effective pharmacotherapy trial consistent with current standards of care. Reasons such as limited patient adherence and\/or physician awareness of guidelines must be identified and redressed to ameliorate the patient, healthcare system, and economic burdens associated with OCD.<\/jats:p>","DOI":"10.1017\/s1092852900023956","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T05:07:10Z","timestamp":1470114430000},"page":"695-703","source":"Crossref","is-referenced-by-count":6,"title":["Adequacy of Pharmacotherapy Among Medicaid-Enrolled Patients Newly Diagnosed with Obsessive-Compulsive Disorder"],"prefix":"10.1017","volume":"14","author":[{"given":"Cheryl S.","family":"Hankin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorrin M.","family":"Koran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Bronstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald W.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Culpepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Knispel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin D.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900023956_ref026","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A254"},{"key":"S1092852900023956_ref018","first-page":"102","article-title":"Economic costs of obsessive-compulsive disorder","volume":"8","author":"DuPont","year":"1995","journal-title":"Med Interface"},{"key":"S1092852900023956_ref020","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.186.6.525"},{"key":"S1092852900023956_ref013","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0514"},{"key":"S1092852900023956_ref005","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.5.669"},{"key":"S1092852900023956_ref036","first-page":"1","article-title":"Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression","volume":"12","author":"Trivedi","year":"2007","journal-title":"CNS Spectr."},{"key":"S1092852900023956_ref025","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.101"},{"key":"S1092852900023956_ref037","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.11.1403"},{"key":"S1092852900023956_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6185(02)00228-1"},{"key":"S1092852900023956_ref001","first-page":"5","article-title":"Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am J Psychiatry"},{"key":"S1092852900023956_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2007.05.016"},{"key":"S1092852900023956_ref021","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1904"},{"key":"S1092852900023956_ref015","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800360042006"},{"key":"S1092852900023956_ref032","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1458"},{"key":"S1092852900023956_ref011","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0611"},{"key":"S1092852900023956_ref033","first-page":"1725","article-title":"Clinical practice guidelines on trial","volume":"156","author":"Hayward","year":"1997","journal-title":"CMAJ"},{"key":"S1092852900023956_ref022","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900011068"},{"key":"S1092852900023956_ref029","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000336756.65308.83"},{"key":"S1092852900023956_ref024","first-page":"1047","volume-title":"The American Psychiatric Publishing Textbook of Clinical Psychiatry","author":"Marangell","year":"2003"},{"key":"S1092852900023956_ref030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064135"},{"key":"S1092852900023956_ref016","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700025484"},{"key":"S1092852900023956_ref028","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X178838"},{"key":"S1092852900023956_ref031","doi-asserted-by":"publisher","DOI":"10.1002\/da.20009"},{"key":"S1092852900023956_ref002","volume-title":"Clinical Practice Guidelines: Directions of a New Program","year":"1990"},{"key":"S1092852900023956_ref008","first-page":"443","article-title":"Undertreatment of panic disorder in primary care: role of patient and physician characteristics","volume":"15","author":"Roy-Byrne","year":"2002","journal-title":"J Am Board Fam Pract"},{"key":"S1092852900023956_ref010","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.1.55"},{"key":"S1092852900023956_ref014","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/ajhp\/57.21.1972","article-title":"Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization","volume":"57","author":"Koran","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"S1092852900023956_ref003","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.593"},{"key":"S1092852900023956_ref023","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0503"},{"key":"S1092852900023956_ref034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911093211906"},{"key":"S1092852900023956_ref035","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410230060008"},{"key":"S1092852900023956_ref027","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1557(200011)9:6<521::AID-PDS525>3.0.CO;2-K"},{"key":"S1092852900023956_ref009","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.12.2230"},{"key":"S1092852900023956_ref007","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1999"},{"key":"S1092852900023956_ref012","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200205000-00003"},{"key":"S1092852900023956_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70177-5"},{"key":"S1092852900023956_ref019","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.2.276"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900023956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T03:18:18Z","timestamp":1556594298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900023956\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1092852900023956"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900023956","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}